Skip to main content
Clinical Trials/ISRCTN38734433
ISRCTN38734433
Active, not recruiting
未知

Better Outcomes For Everybody (BOFE) evaluates the effectiveness and cost-effectiveness of a pharmacist-led intervention, delivered by community pharmacists in collaboration with physicians, in improving disease control, compared with usual care, in asthma and COPD patients during and after COVID-19: study protocol for a pragmatic, parallel randomised controlled trial

SOFAD srl0 sites835 target enrollmentJune 15, 2021

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
SOFAD srl
Enrollment
835
Status
Active, not recruiting
Last Updated
2 years ago

Overview

Brief Summary

2021 Protocol article in http://dx.doi.org/10.1097/MD9.0000000000000158 Peer-reviewed protocol article (added 12/07/2022)

Registry
who.int
Start Date
June 15, 2021
End Date
November 30, 2023
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
SOFAD srl

Eligibility Criteria

Inclusion Criteria

  • Pharmacies must have:
  • 1\. A private area for private consultation with patients
  • 2\. And/or telephone, smartphone, tablet or other devices allowing remote consultation with their patients if required due to COVID\-19 restrictions
  • 3\. An internet connection
  • Pharmacists must:
  • 1\. Be qualified and registered with the Italian Pharmacy Board practising in Italy
  • 2\. Have experiences in providing advice to patients
  • 3\. Have already provided one or more services, such as blood pressure monitoring, smoking cessation, cholesterol monitoring, signposting, food intolerance testing (this will be verified during the recruitment process asking for a self\-declaration)
  • 4\. Be able to attend the full training session(s)
  • Patients must:

Exclusion Criteria

  • Pharmacies must be excluded if they:
  • 1\. Have no internet access
  • 2\. No consultation room or no telephone, smartphone, tablet or other devices allowing remote consultation with their patients if required due to COVID\-19 restrictions
  • 3\. Are currently involved in any other clinical pharmacy research project
  • Patients must be excluded if they:
  • 1\. Have a terminal illness (defined as an advanced stage of a disease with an unfavourable prognosis and no known cure) as identified by the pharmacists through the prescription coding
  • 2\. Are currently enrolled in another clinical trial
  • 3\. Do not self\-administer their medications (e.g. inhaler)
  • 4\. Are not able to communicate well in Italian, both written and spoken

Outcomes

Primary Outcomes

Not specified

Similar Trials